FDA May Reclassify ECT Devices
Price: $ 168.50
5(196)
The FDA may reclassify electroconvulsive therapy devices from class III to class II. The FDA is accepting public comments on the change until March 28.
The Dangerous Truth About Electroshock (ECT) - Mental Health
When to consider electroconvulsive therapy (ECT) - Kellner - 2020
Advocacy Update: February 2019
Electroshock Therapy (ECT) Trial – Jury Finds Somatics Failed to
FDA Looks to Expand Electroshock Use Despite Significant Risks and
Electroconvulsive Therapy
FDA May Reclassify ECT Devices
Electroconvulsive therapy for depression: 80 years of progress
FORM S-1/A
How to Report Your ECT Injury to the FDA - Life After ECT
You may also like
